Noticias e investigación

Metales tóxicos

Los metales tóxicos normalmente están presentes en cantidades muy pequeñas en nuestro organismo, pero la exposición continua a ellos o las anormalidades en el mecanismo de eliminación del exceso de estos metales pueden provocar problemas muy serios y, en ocasiones, con síntomas difíciles de diagnosticar. Por ejemplo:

  • El plomo puede provocar náusea, fatiga, dificultades de comprensión y atención en niños, problemas de desarrollo, etc.
  • El mercurio puede provocar depresión, fatiga, insomnio, etc.
  • El aluminio y el mercurio pueden ser un factor en la enfermedad de Alzheimer.
  • Hoy en día es cada vez más común encontrar niveles excesivos de metales tóxicos debido a la contaminación ambiental, la utilización de fertilizantes químicos, etc.
  • Los metales tóxicos se consideran un factor en el desarrollo del autismo.

EDTA Review published in Occupational Medicine & Health Affairs 2016

EDTA: Ethylene Diamine Tetra Acetic Acid - A Review by E. Blaurock-Busch, published in Occupational Medicine & Health Affairs 2016 4:4

Chelation therapists around the world incorporate EDTA treatments in their daily practice, often unaware of the chemical differences of the various chelating agents. Misunderstandings increase the risk of iatrogenic accidents. This information aims to prevent this.

Download article

Comparing DMSA, DMPS and EDTA

Original Research Paper publ Jan 2014, British Journal of Medicine and Medical Research:

Comparison of Chelating Agents DMPS, DMSA and EDTA for the Diagnosis and Treatment of Chronic Metal Exposure

The chelating agents most commonly used to treat chronic metal overexposures are DMSA, DMPS and EDTA. We evaluated and compared the effectiveness of each of those chelating agents and statistically determined what metals are best bound. Based on the metal binding capacity and practicality of use, we determined that intravenously applied DMPS is best used as a provocation or mobilization test.

Read or download research paper

DMSA and DMPS: Does more of a chelator increase metal binding and excretion?

At present, it is assumed that the application of higher amounts of a chelating agent increases metal binding and thus the detoxification process. This does not seem to be the case. The manufacturer of DMPS (Dimaval), Heyl Berlin published data that indicate that for instance 2 or more ampules of DMPS intravenously applied do not result in double binding.

The same principle applies to other chelating agents. For example, when comparing 500mg to 1000mg DMSA applied orally, results do not increase as expected.

Study data and statistics are included.

Full article (in German only):

Diagnostic before Chelation Treatment

Chelation therapy is used  for the treatment of chronic metal overexposures of varying degrees and appropriate diagnostics allow proper and safe treatment. The use of diagnostics aids the physician in setting therapy schedules, allows proper selection of the most useful chelating agent for the patient's condition, and monitors treatment success.

For detailed information, see our books.